UPDATE 1-FDA staff raise concerns about Intellipharma’s opioid painkiller

July 24 (Reuters) – U.S. Food and Drug Administrationscientists on Monday raised concerns that IntellipharmaceuticsInternational Inc failed to provide data from studiestesting the abuse potential of its long-acting opioidpainkiller.
The post UPDATE 1-FDA staff raise concerns about Intellipharma’s opioid painkiller appeared first on RocketNews | Top News Stories From Around the Globe.